Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Trading Update

21 Jan 2025 07:00

RNS Number : 0148U
Argentex Group PLC
21 January 2025
 

 

21 January 2025

 

Argentex Group PLC

("Argentex" or the "Group")

Trading update

 

 

Full year revenues ahead of expectations; margins in line

Revenue diversification plans on track

 

 

Argentex Group PLC (AIM: AGFX), the global specialist in currency risk management and alternative banking, today announces a trading update for the 12-month period ended 31 December 2024.

Highlights

· Full year revenues* marginally higher than FY23 and ahead of market expectation

· Full year EBITDA margin* in line with expectation

· Australian and Dubai licences granted in year and regions now fully operational

· Argentex Global Platform build progressing to plan

· Leadership strengthened across the business

Trading Update

The Board expects to report FY24 revenues of approximately £50.3m*, marginally ahead of FY23 (£49.9m), and ahead of our mid £40 millions original expectations for the year. Whilst the adverse market conditions experienced during 2023 in the core FX business continued into the first quarter of 2024, trading momentum improved subsequently, with the business returning to year on year growth in the second half and revenues in H2 exceeding those generated in H1.

The Group continues to make good progress across its core areas of strategic focus, in particular diversifying its revenue streams through entering additional geographies and launching new products and services. Notwithstanding this continued investment into its strategic pillars the Board is confident that it will meet the original low single digit EBITDA margin expectation for the year.

 

Strong Momentum in Overseas Expansion

We were delighted to be granted licences to operate in both Australia and Dubai during the year, which was a key strategic priority and will significantly increase our addressable market. Both offices are now fully staffed and operational and should contribute to revenues this year.

In Australia, we were granted an Australian Financial Services Licence (AFSL) in May 2024. The licence, granted by the Australian Securities and Investments Commission (ASIC), allows Argentex's Australian entity (Argentex Pty Ltd) to offer bespoke currency risk management solutions and global accounts to wholesale clients across Australia.

In Dubai, we have announced the launch of Argentex (DIFC) Ltd, a fully licensed subsidiary regulated by the Dubai Financial Services Authority (DFSA). Led by our UAE Managing Director Jamil Khammu, we have a highly experienced team in place to serve sophisticated corporate and institutional clients across the DIFC and broader UAE market. Argentex (DIFC) Ltd is fully regulated under a Category 3A DFSA licence, enabling the team to offer comprehensive FX and payment services.

 

 

Product Diversification on Track

We continue to diversify into the broader payments and alternative banking markets, which will bring additional and more visible revenue streams; increase the Group's overall addressable market and improve customer retention.

To support this initiative, we made a number of key technology hires in the period to help re-platform the business onto one Argentex Global Platform ("AGP") and roll out a new suite of services. In particular, Tim Rudman has joined as Chief Operating Officer, alongside a number of other key hires. Tim and his team have developed a detailed product and technology roadmap with a key focus on automation, efficiency and improving the customer experience via a self-serve model. Progress to date has been excellent: milestones have been met ahead of schedule and we remain on track to launch new services in H2 2025. 

 

Jim Ormonde, CEO, said:

"We have made substantial strategic and operational progress in 2024 with a focus on revenue diversification through geographical expansion and the launch of new products and services, whilst making the business more efficient and resilient from an operational perspective. We have added significant expertise across the business including permanent appointments to our executive team and new experienced leadership within alternative banking, operations and technology. It has been a busy year and I am delighted with the progress made. We have invested for growth in 2024 and have made major changes to the business. With a strong team now in place, and a clear roadmap for the future, I am excited about the prospects for 2025 as multiple new profit generating revenue streams commence."

 

*FY24 results are yet to be subject to statutory audit.

 

For further information, please contact:

 

Argentex Group PLC

Jim Ormonde - Chief Executive Officer

Guy Rudolph - Chief Financial Officer

investorrelations@argentex.com

 

Teneo (Financial PR)

James Macey-White / Victoria Boxall / Rashida Salemahomed

argentex@teneo.com, 020 7260 2700

 

Singer Capital Markets (Nominated Adviser and Broker)

Tom Salvesen / James Maxwell / Asha Chotai

020 7496 3000

 

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation ("MAR") which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018; as amended. Upon publication of this announcement, the inside information is now considered to be in the public domain for the purposes of MAR.

 

About Argentex

Argentex (AIM: AGFX) is a global expert in currency risk management and alternative banking. Established in 2012 and headquartered in London, Argentex listed on London's AIM market in mid-2019 and has since added operations in Amsterdam, Dubai and Australia.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKKBPABKDODB
Date   Source Headline
26th Feb 20212:58 pmRNSDirector/PDMR Shareholding
17th Feb 20213:12 pmRNSHolding(s) in Company
9th Feb 20212:34 pmRNSHolding(s) in Company
20th Jan 20217:00 amRNSTrading update and Board changes
20th Nov 20207:00 amRNSInterim Results
19th Nov 20204:53 pmRNSHolding(s) in Company
4th Nov 20207:00 amRNSNotice of interim results
12th Oct 20207:00 amRNSDirector Declaration
12th Oct 20207:00 amRNSTrading Statement
6th Oct 20204:40 pmRNSSecond Price Monitoring Extn
6th Oct 20204:35 pmRNSPrice Monitoring Extension
30th Sep 20204:40 pmRNSSecond Price Monitoring Extn
30th Sep 20204:35 pmRNSPrice Monitoring Extension
21st Sep 20205:50 pmRNSChange of Registered Office
11th Sep 20202:18 pmRNSAGM Statement
7th Sep 20204:36 pmRNSPrice Monitoring Extension
10th Aug 20207:17 amRNSAnnual Report and Notice of Annual General Meeting
3rd Aug 20207:00 amRNSFull year results for period ending 31 March 2020
29th Jul 20204:35 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSNotice of Full Year Results
8th Jul 20205:24 pmRNSHolding(s) in Company
29th Jun 20209:11 amRNSHolding(s) in Company
27th May 20207:00 amRNSArgentex Group announces new headquarters
26th May 20204:40 pmRNSSecond Price Monitoring Extn
26th May 20204:35 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
1st Apr 20205:40 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSTrading Update
27th Mar 20204:41 pmRNSSecond Price Monitoring Extn
27th Mar 20204:36 pmRNSPrice Monitoring Extension
25th Mar 20204:00 pmRNSDirector/PDMR Shareholding
18th Mar 202011:46 amRNSDirector/PDMR Shareholding
17th Mar 20204:43 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20204:41 pmRNSDirector/PDMR Shareholding
11th Mar 20204:41 pmRNSHolding(s) in Company
11th Mar 20204:41 pmRNSSecond Price Monitoring Extn
11th Mar 20204:35 pmRNSPrice Monitoring Extension
9th Mar 20204:41 pmRNSSecond Price Monitoring Extn
9th Mar 20204:37 pmRNSPrice Monitoring Extension
27th Feb 202012:07 pmRNSSecond Price Monitoring Extn
27th Feb 202012:02 pmRNSPrice Monitoring Extension
26th Feb 202012:08 pmRNSSecond Price Monitoring Extn
26th Feb 202012:02 pmRNSPrice Monitoring Extension
24th Feb 20204:40 pmRNSSecond Price Monitoring Extn
24th Feb 20204:35 pmRNSPrice Monitoring Extension
20th Nov 20197:00 amRNSInterim Results Statement
7th Oct 20197:00 amRNSTrading Update
5th Aug 20197:00 amRNSAppointment of Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.